Literature DB >> 18807206

Aliskiren: a rapidly, expanding role in the management of recalcitrant hypertension and renal disease.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18807206     DOI: 10.1007/s11255-008-9471-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  5 in total

Review 1.  Aliskiren: renin inhibitor for hypertension management.

Authors:  Judy W M Cheng
Journal:  Clin Ther       Date:  2008-01       Impact factor: 3.393

Review 2.  Inhibition of the renin-angiotensin system and chronic kidney disease.

Authors:  Kostas C Siamopoulos; Rigas G Kalaitzidis
Journal:  Int Urol Nephrol       Date:  2008-08-14       Impact factor: 2.370

3.  Aliskiren combined with losartan in type 2 diabetes and nephropathy.

Authors:  Hans-Henrik Parving; Frederik Persson; Julia B Lewis; Edmund J Lewis; Norman K Hollenberg
Journal:  N Engl J Med       Date:  2008-06-05       Impact factor: 91.245

4.  Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.

Authors:  Karl Andersen; Myron H Weinberger; Brent Egan; Christian M Constance; Mohammed A Ali; James Jin; Deborah L Keefe
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

5.  Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.

Authors:  Naomi D L Fisher; A H Jan Danser; J Nussberger; William P Dole; Norman K Hollenberg
Journal:  Circulation       Date:  2008-06-16       Impact factor: 29.690

  5 in total
  1 in total

Review 1.  Direct renin inhibitors: ONTARGET for success?

Authors:  Yasmin Pasha; Paul Gusbeth-Tatomir; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2009-03-19       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.